COMBINATION THERAPIES FOR INHIBITING INTEGRIN-EXTRACELLULAR MATRIX INTERACTIONS

摘要

The present application relates to compositions of extracellular matrix (ECM)antagonists and their use in methods for treating angiogenic-dependentconditions. The ECM antagonists can bind the same or different ECM component.The present application also relates to compositions of ECM antagonists andcancer therapies and their use in methods for preventing, treating or managingangiogenic- dependent conditions such as cancer.